Niaid preclinical development support - support for production and testing of ADC6-HIV GP140 and ADC7-HIV GP140
Ended Awarded Last action
- Contract number
- HHSN27200032
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,731,476
Award facts
- Contract value 100% obligated
- $3,731,476.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Definitize Change Order | $115,996 | |
| Change Order | $141,348 | |
| Other Administrative Action | $0 | |
| Change Order | $213,660 | |
| Change Order | $81,463 | |
| Original award | $3,179,009 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $3,731,476.00, is for the NIAID Preclinical Development Support program, specifically to support the production and testing of ADC6-HIV GP140 and ADC7-HIV GP140. The prime contractor is Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods that specializes in the development of gene therapies, vaccines, and immunotherapies. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for various infectious diseases. This specific contract supports preclinical development services, including cGMP manufacturing, process development, analytical testing, and stability studies for these HIV vaccine candidates.
Quick answers
Who was awarded contract HHSN27200032?
HHSN27200032 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 25, 2016.
How much is contract HHSN27200032 worth?
The government has obligated $3,731,476 on HHSN27200032.
Is contract HHSN27200032 an order under another contract?
Yes. HHSN27200032 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200032 competed?
The extent of competition for HHSN27200032 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award